Literature DB >> 24142156

On the prevalence of KRAS mutations in GISTs.

Riccardo Ricci1, Angelo Paolo Dei Tos, Guido Rindi.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24142156     DOI： 10.1007/s00428-013-1496-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  7 in total

1.  KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors.

Authors:  Claudia Miranda; Martina Nucifora; Francesca Molinari; Elena Conca; Maria Chiara Anania; Andrea Bordoni; Piercarlo Saletti; Luca Mazzucchelli; Silvana Pilotti; Marco A Pierotti; Elena Tamborini; Angela Greco; Milo Frattini
Journal:  Clin Cancer Res       Date:  2012-01-26       Impact factor: 12.531

Review 2.  GISTogram: a graphic presentation of the growing GIST complexity.

Authors:  Riccardo Ricci; Angelo Paolo Dei Tos; Guido Rindi
Journal:  Virchows Arch       Date:  2013-08-23       Impact factor: 4.064

3.  V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.

Authors:  A Agaimy; L M Terracciano; S Dirnhofer; L Tornillo; A Foerster; A Hartmann; M P Bihl
Journal:  J Clin Pathol       Date:  2009-07       Impact factor: 3.411

4.  Molecular characterization of an Italian series of sporadic GISTs.

Authors:  P Origone; S Gargiulo; L Mastracci; A Ballestrero; L Battistuzzi; C Casella; D Comandini; R Cusano; A P Dei Tos; R Fiocca; A Garuti; P Ghiorzo; C Martinuzzi; L Toffolatti; G Bianchi Scarrà
Journal:  Gastric Cancer       Date:  2013-01-05       Impact factor: 7.370

5.  Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).

Authors:  Marc Daniels; Irene Lurkin; Roland Pauli; Erhard Erbstösser; Uwe Hildebrandt; Karsten Hellwig; Uwe Zschille; Petra Lüders; Gabriele Krüger; Jürgen Knolle; Bernd Stengel; Friedrich Prall; Kay Hertel; Hartmut Lobeck; Brigitte Popp; Franz Theissig; Peter Wünsch; Ellen Zwarthoff; Abbas Agaimy; Regine Schneider-Stock
Journal:  Cancer Lett       Date:  2011-08-06       Impact factor: 8.679

6.  Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.

Authors:  Olga Martinho; António Gouveia; Marta Viana-Pereira; Paula Silva; Amadeu Pimenta; Rui Manuel Reis; José Manuel Lopes
Journal:  Histopathology       Date:  2009-07       Impact factor: 5.087

7.  No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.

Authors:  Jerzy Lasota; Liqiang Xi; Tiffany Coates; RaShonda Dennis; Moses O Evbuomwan; Zeng-Feng Wang; Mark Raffeld; Markku Miettinen
Journal:  Mod Pathol       Date:  2013-05-24       Impact factor: 7.842
  7 in total
  1 in total

1.  Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors.

Authors:  Xiangfei Sun; Ping Shu; Yong Fang; Wei Yuan; Qiang Zhang; Jianyi Sun; Min Fu; Anwei Xue; Xiaodong Gao; Kuntang Shen; Yingyong Hou; Yihong Sun; Jing Qin; Xinyu Qin
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.